Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT01162473

Milk Oral Immunotherapy in Children to Treat Food Allergy

A Study of the Efficacy of Milk Oral Immunotherapy in Children

Sponsor: Children's Hospital of Philadelphia

Interventions Food Challenge Milk Oral Immunotherapy Milk Protein Powder

Updated 7 times since 2017 Last updated: May 11, 2015 Started: Jun 30, 2010 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Milk Hypersensitivity and is currently completed. Children's Hospital of Philadelphia leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Dec 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Dec 2021 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed Phase 0

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Hospital of Philadelphia

Data source: Children's Hospital of Philadelphia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States